Skip to main content

HRB National Drugs Library

Home > EMCDDA–Europol Joint report on a new psychoactive substance: AH-7921. (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide).

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: AH-7921. (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

[img] PDF (Report on a new psychoactive substance: AH-7921) - Published Version
454kB

The EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that sufficient information had been accumulated to merit the production of a Joint Report on AH-7921 as stipulated by Article 5.1 of the Decision.

The following street names have been reported: ‘AH-7921’ and ‘doxylan’.


Item Type
Report
Publication Type
International, Report
Drug Type
New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
Date
January 2014
Pages
23 p.
Publisher
European Monitoring Centre for Drugs and Drug Addiction & Europol
Corporate Creators
Europol, European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote
View
Accession Number
HRB (Electronic Only)
Related (external) link
Subjects
B Substances > New (novel) psychoactive substances
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
VA Geographic area > Europe

Repository Staff Only: item control page